Dr. Dimitrios Philippes Agaliotis, MD

Dr. Agaliotis practices at UF Health Rehabilitation Hospital - North in Jacksonville, Florida, part of UF Health.

Dr. Agaliotis' NPI, 1790764272, was assigned on January 12, 2006. Dr. Agaliotis graduated from University of Athens in 1981. Dr. Agaliotis holds Florida license ME0065592.

Dr. Agaliotis' primary practice is UF Health Rehabilitation Hospital - North, at 15255 Max Leggett Pkwy, 2nd and 3rd Floors, Jacksonville, FL 32218 in Duval County. The practice phone is (904) 456-8001.

Dr. Agaliotis' primary practice is UF Health Rehabilitation Hospital - North in Jacksonville, Florida, part of UF Health. Dr. Agaliotis is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is GenesisCare. Dmand AI also links Dr. Agaliotis to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agaliotis practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Agaliotis' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Agaliotis is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Agaliotis' licenses on file in 2 states: Florida and Alabama.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Agaliotis treats.

CMS data shows 1,833 Medicare services from Dr. Agaliotis across 8 procedure codes in 2024, for 683 Medicare patients. Medicare paid $165,053 for them.

CMS counts 683 Medicare patients who saw Dr. Agaliotis in 2024. The largest group is 75 to 84, with 310 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agaliotis' median patient age at 77, with 59% women.

In 2024, Dr. Agaliotis wrote 938 Medicare Part D claims for 176 patients. 67% of them were for generic drugs. CMS names the drug for 731 of them, across 22 drugs with 11 or more claims each, at $1,793,515 in total drug cost. In 2023, CMS named 638 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Agaliotis for performance year 2024, reported individually. Dr. Agaliotis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Agaliotis as offering telehealth.

Dmand AI links 8 papers to Dr. Agaliotis. The most frequent topics are Bone Marrow, Bone Marrow Transplantation and Hematopoietic Stem Cells. Dr. Agaliotis has published most often in Bone Marrow Transplant. Dr. Agaliotis' most frequent co-authors are Karen Keyse Fields, MD, John William Hiemenz, MD and Paul Edward Zorsky, MD.

CMS Open Payments shows 337 general payments to Dr. Agaliotis from 47 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. AstraZeneca Pharmaceuticals LP paid the most, $9,547.

Dmand AI lists 2 awards for Dr. Agaliotis, most recently CMS Stage 1 EHR in 2013.

Dr. Agaliotis graduated from University of Athens in 1981. Dr. Agaliotis is a member of ACP.

Dr. Agaliotis is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.